Cargando…
Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations
SHP-2 (encoded by PTPN11) is a ubiquitously expressed protein tyrosine phosphatase required for signal transduction by multiple different cell surface receptors. Humans with germline SHP-2 mutations develop Noonan syndrome or LEOPARD syndrome, which are characterized by cardiovascular, neurological...
Autores principales: | Bauler, Timothy J., Kamiya, Nobuhiro, Lapinski, Philip E., Langewisch, Eric, Mishina, Yuji, Wilkinson, John E., Feng, Gen-Sheng, King, Philip D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046097/ https://www.ncbi.nlm.nih.gov/pubmed/21068439 http://dx.doi.org/10.1242/dmm.006130 |
Ejemplares similares
-
Skeletal malformation and the SHP-2 pathway
Publicado: (2011) -
Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice
por: Lapinski, Philip E., et al.
Publicado: (2013) -
Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2–Induced Gastrulation Defects
por: Jopling, Chris, et al.
Publicado: (2007) -
SHP2 Regulates Chondrocyte Terminal Differentiation, Growth Plate Architecture and Skeletal Cell Fates
por: Bowen, Margot E., et al.
Publicado: (2014) -
SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth
por: Fornaro, Mara, et al.
Publicado: (2006)